A new radiation responsive esculin-derived molecular gel has been developed at the City College of New York (CCNY) that can simplify and improve the quality of cancer imaging, according to a release from CCNY.
The molecular gel is derived from horse chestnuts and will enhance the optical photon output in image mapping to better detect cancer. The gel was developed through a study led by George John, professor at CCNY, and in collaboration with Jan Grimm, a physician scientist at the Sloan Ketterin Institute.
“Tailoring bio-based materials to synthesize thixotropic thermo-reversible hydrogels offers image-aiding systems which are not only functional but also potentially economical, safe, and environmentally friendly,” said John.
“The possibility of developing a topical application from the gel makes this innovation an attractive potential improvement to current techniques of cancer imaging with Cerenkov light,” added Grimm.